(Q38213904)

31 August 2017

0 references

Acarbose monotherapy and weight loss in Eastern and Western populations with hyperglycaemia: an ethnicity-specific meta-analysis (English)

1 reference

31 August 2017

1 reference

1 reference

Y Li

1

1 reference

31 August 2017

Y Tong

2

1 reference

31 August 2017

Y Zhang

3

1 reference

31 August 2017

L Huang

4

1 reference

31 August 2017

T Wu

5

1 reference

31 August 2017

N Tong

6

1 reference

31 August 2017

publication date

23 May 2014

1 reference

International Journal of Clinical Practice

31 August 2017

published in

1 reference

31 August 2017

volume

68

1 reference

31 August 2017

issue

11

1 reference

31 August 2017

page(s)

1318-1332

1 reference

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Impact of overweight on the risk of developing common chronic diseases during a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Obesity, weight loss and prognosis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Effect of acarbose on insulin sensitivity in elderly patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Glycaemic responses to glucose and rice in people of Chinese and European ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus. The Finnish Acargbos Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

Copy number polymorphism of the salivary amylase gene: implications in human nutrition research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12467

21 January 2018

Identifiers

DOI

10.1111/IJCP.12467

1 reference

31 August 2017

1 reference